January–June 2026 compared with January–June 2025 Net sales declined 6% to SEK 9,893m (10,541). The lower net sales were mainly driven by lower selling prices and negative exchange rate effects, which were offset by higher delivery volumes. EBITDA amounted to SEK 2,410m (3,684). The decrease was primarily attributable to lower selling prices, negative exchange rate effects and higher raw material costs.
SCA to float its joint venture in Australia
- Regulatory press release
The leading global hygiene and forest products company SCA and its Australian partner, Pacific Equity Partners (PEP), have decided to float their joint venture in Australia, New Zealand and Fiji on the Australian Securities Exchange (ASX).
A draft of the prospectus for the initial public offering (IPO) was today submitted to the Australian Securities and Investment Commission (ASIC). The listing of the joint venture Asaleo Care (formerly SCA Hygiene Australasia) on the ASX is scheduled to take place in late June or early July 2014.
SCA intends to retain a significant shareholding in Asaleo Care. The Group currently owns 50% of the company. The stock market floatation will dilute SCA’s holding in the company. SCA’s ownership is expected to be approximately 33% following the IPO.
Asaleo Care manufactures and markets consumer tissue and Away-from-Home (AfH) tissue, diapers, feminine care products and incontinence products. Leading brands include TENA, Tork, Sorbent, Libra and Treasures. In 2013, the company reported net sales of AUD 625m (approx. SEK 3.9 billion) and an operating profit of AUD 97m (approx. SEK 610m). The company has about 1,050 full-time employees.
NB: SCA discloses the information provided herein pursuant to the Financial Instruments Trading Act. Submitted for publication on June 2, 2014, at 07:00 CET.
For additional information please contact:
Johan Karlsson, VP Investor Relations, 46 8 788 51 30
Boo Ehlin, VP Media Relations, 46 8 788 51 36